Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Peringkat dalam Saham #27036
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Harga Saham
$2.18
Terakhir disinkronkan: 2026-08-19
Kapitalisasi Pasar
$35.55M
Perubahan (1 hari)
2.57%
Perubahan (1 tahun)
-33.19%
Negara
US
Perdagangan Grace Therapeutics, Inc. (GRCE)

Kategori

Riwayat harga saham Grace Therapeutics, Inc. (GRCE)
Harga penutupan tertinggi: $2.13 pada 2026-08-01

Harga penutupan terendah: $3.24 pada 2024-10-01
Riwayat harga saham Grace Therapeutics, Inc. dari 2024 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -5.78%
2025 -13.39%
2024 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$758.23 6.53%
CH